- Report
- October 2024
- 194 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- October 2024
- 180 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- May 2024
- 150 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- May 2025
- 196 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- July 2024
- 110 Pages
North America
From €4534EUR$4,950USD£3,854GBP
- Report
- November 2024
- 130 Pages
Global
From €4260EUR$4,650USD£3,620GBP
- Report
- August 2024
- 143 Pages
Global
From €4260EUR$4,650USD£3,620GBP
- Report
- October 2024
- 199 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- February 2025
- 302 Pages
Global
From €3847EUR$4,200USD£3,270GBP
- Report
- March 2025
- 150 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- February 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- May 2025
- 67 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 172 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 166 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 162 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- March 2025
- 224 Pages
Global
From €4076EUR$4,450USD£3,465GBP
- Report
- April 2025
- 164 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2025
- 317 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- July 2024
- 130 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- June 2024
- 150 Pages
United States
From €5451EUR$5,950USD£4,632GBP

Pharmaceutical Services Outsourcing (PSO) is a rapidly growing market within the pharmaceutical manufacturing industry. It involves the transfer of certain activities, such as drug development, clinical trials, and manufacturing, from pharmaceutical companies to third-party service providers. This allows pharmaceutical companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. PSO also helps pharmaceutical companies reduce costs, increase efficiency, and improve quality.
The PSO market is segmented into drug development, clinical trials, and manufacturing services. Drug development services include pre-clinical and clinical research, regulatory affairs, and drug safety. Clinical trials services include clinical trial management, data management, and biostatistics. Manufacturing services include active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging and labeling.
Notable companies in the PSO market include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more